Module

Depression and Suicidal Risk Associated With HCV Treatment

Source: Depression Associated With HCV Infection and Its Therapy: Impact on Patient Management

Depression and Suicidal Risk Associated With HCV Treatment

CME Program Director: Rafael Esteban-Mur, MD

Faculty:

Charles L. Raison, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

Cite the prevalence of depression during treatment with HCV therapy
Summarise the impact of depression on treatment outcomes in patients with hepatitis C
Recall the risk factors for development of depression during HCV therapy
Describe the risk of suicide in HCV-infected patients receiving therapy

Topics covered include:

Page 1

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.